Nucleic Acid Isolation and Purification Kits Market to Reach USD 4.82 Billion by 2030

Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) – Global Forecast to 2030

The global Nucleic Acid Isolation and Purification Kits Market is projected to grow from USD 3.02 billion in 2025 to USD 4.82 billion by 2030, registering a CAGR of 9.8% during the forecast period. Sustained expansion in molecular diagnostics, increasing PCR/qPCR and NAAT testing volumes, and the broader integration of genomics into clinical and research workflows are key factors fueling market growth.

A primary growth driver is the expanding network of hospital laboratories, diagnostic chains, and high-throughput reference labs performing routine molecular diagnostics and surveillance testing. These laboratories depend heavily on reliable DNA and RNA extraction workflows to support infectious disease testing, oncology profiling, genetic screening, and public health monitoring. As a result, demand for spin-column kits, magnetic bead-based kits, and reagent-based extraction solutions remains strong and recurring.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36573704

DNA Isolation Kits Led the Market by Type in 2024

By type, the market is segmented into DNA isolation kits, RNA isolation kits, total nucleic acid isolation kits, and other specialized kits. In 2024, DNA isolation kits accounted for the largest market share.

DNA extraction remains a foundational step across multiple diagnostic and research workflows. Hospitals and diagnostic centers routinely extract DNA for genetic testing, oncology diagnostics, hereditary disease screening, and confirmatory molecular assays. The high frequency of testing and consistent consumable usage contribute to stable and repeatable revenue streams for manufacturers. As personalized medicine and oncology profiling continue to expand, DNA extraction demand is expected to remain robust.

Magnetic Bead-Based Methods Dominated in 2024

By method, the market includes magnetic bead-based, column-based (silica spin columns), reagent-based, and other technologies. Magnetic bead-based methods held the dominant share in 2024, largely due to their compatibility with automation and scalability for high-throughput laboratories.

Magnetic bead systems integrate seamlessly with automated extractors and liquid handling platforms, which are widely deployed in large hospital labs and centralized reference laboratories. Their ability to deliver consistent yields, reduce manual intervention, and support rapid turnaround times makes them particularly suitable for high-volume PCR/qPCR and NAAT workflows. As laboratory automation continues to expand, magnetic bead-based extraction is expected to maintain a competitive advantage.

Asia Pacific to Record the Fastest Growth Through 2030

Regionally, Asia Pacific is projected to grow at the fastest rate between 2025 and 2030. This growth is driven by the rapid expansion of molecular diagnostics infrastructure across hospitals, diagnostic chains, and public health laboratories.

Countries across the region are strengthening PCR and NAAT capacity while scaling disease surveillance programs, resulting in sustained and repeatable extraction kit demand. In parallel, increased adoption of next-generation sequencing (NGS) in clinical research and genomic profiling is driving the need for high-quality DNA and RNA preparation workflows. Expanding healthcare investments and laboratory modernization initiatives further support regional growth momentum.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=36573704

Competitive Landscape

Key companies operating in the nucleic acid isolation and purification kits market include Thermo Fisher Scientific, QIAGEN, F. Hoffmann-La Roche, Agilent Technologies, Inc., and Takara Bio Inc., along with several other regional and global participants.

These companies are focusing on automation-ready platforms, improved reagent chemistries, and workflow-integrated solutions to strengthen their competitive positioning in both clinical diagnostics and research applications.

Market Outlook

As molecular diagnostics becomes a standard component of routine healthcare and public health surveillance, nucleic acid extraction remains a critical enabling step. Continued investments in automation, genomics, and precision medicine are expected to sustain steady growth in the nucleic acid isolation and purification kits market through 2030.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-and-purification-kits-market-36573704.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Nucleic Acid Isolation and Purification Kits Market to Reach USD 4.82 Billion by 2030

Erythropoietin (EPO) Biomarkers Market to Reach USD 1.06 Billion by 2030 Amid Rising CKD and Oncology-Linked Anemia Cases

Erythropoietin (EPO) Biomarkers Market by Type (Erythropoietin Alfa, Erythropoietin Zeta), Application (Anemic disorder, Cancer, End-stage renal disorder), End User (Hospitals, Diagnostic Centers) – Global Forecast to 2030

The global Erythropoietin (EPO) Biomarkers Market is projected to grow from USD 0.69 billion in 2025 to USD 1.06 billion by 2030, registering a CAGR of 9.0% during the forecast period. Market expansion is primarily driven by the increasing prevalence of chronic kidney disease (CKD), rising incidence of anemia-related disorders, and advancements in biomarker-based diagnostics supporting precision medicine initiatives.

EPO biomarkers play a critical role in evaluating erythropoiesis activity, guiding erythropoiesis-stimulating agent (ESA) therapy, and monitoring treatment response in nephrology and oncology care. As healthcare systems emphasize individualized treatment protocols and value-based care, demand for reliable and high-throughput EPO testing solutions continues to strengthen globally.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246612734

Hospitals Led the Market by End User in 2024

Hospitals accounted for the largest share of the EPO biomarkers market in 2024. Their dominance is attributed to centralized laboratory infrastructure capable of high-volume anemia screening and therapy monitoring. Hospitals manage complex CKD and oncology patient populations, where EPO testing is routinely integrated with reticulocyte counts, ferritin levels, and other hematologic parameters to enable comprehensive diagnostics.

Advanced immunoassay systems, skilled laboratory personnel, and established reimbursement pathways allow hospitals to deliver rapid turnaround times. This supports accurate dosing decisions for erythropoiesis-stimulating agents, particularly in inpatient and outpatient nephrology settings. The growing emphasis on integrated diagnostic pathways further reinforces hospital-based testing volumes.

Cancer Segment Emerged as the Fastest-Growing Application

By application, the cancer segment is expected to register the highest growth rate during the forecast period. The increase in chemotherapy-induced anemia cases has heightened the need for real-time biomarker monitoring to optimize ESA therapy.

Oncology centers are increasingly deploying multiplex immunoassays to simultaneously measure EPO, reticulocytes, and ferritin levels, enabling precise dosing adjustments for agents such as epoetin alfa. In addition, biomarker-driven clinical trials and precision medicine initiatives are accelerating adoption, particularly in hematological malignancies and solid tumors. The growing availability of biosimilars and their evaluation in oncology protocols further supports market expansion within this segment.

North America Dominated the Global Market in 2024

North America held the largest regional share of the EPO biomarkers market in 2024. The region’s leadership reflects a strong concentration of academic medical centers, integrated health systems, and diagnostic innovators that have rapidly adopted advanced immunoassay and automated analyzer platforms.

Favorable reimbursement structures for anemia monitoring, early regulatory acceptance of novel diagnostic technologies, and payer-backed precision nephrology initiatives continue to drive regional growth. Additionally, significant pharmaceutical and biotechnology investments in EPO-based clinical trials and real-world evidence studies further strengthen North America’s position in global revenues.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=246612734

Competitive Landscape

Key players operating in the EPO biomarkers market include Amgen Inc., Biocon Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck KGaA, Pfizer Inc., Siemens Healthineers, and 3SBio Group.

These companies are actively investing in advanced assay technologies, biosimilar development, and integrated diagnostic platforms to enhance clinical decision support and expand global market presence.

Market Outlook

With rising CKD prevalence, expanding oncology pipelines, and increasing adoption of biomarker-driven therapeutic strategies, the EPO biomarkers market is poised for steady growth through 2030. Continued innovation in immunoassay technologies and precision medicine frameworks will remain central to sustaining long-term demand.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/erythropoietin-epo-biomarkers-market-246612734.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Erythropoietin (EPO) Biomarkers Market to Reach USD 1.06 Billion by 2030 Amid Rising CKD and Oncology-Linked Anemia Cases

Biopesticides Market Size, Share, Latest Trends, Growth Drivers, Opportunities, Leading Key Players, and Future Outlook (2025-2030)

“MarketsandMarkets™”
Biopesticides Market by Type (Bioinsecticides, Biofungicides, Bionematicides), Crop Type (Cereals & Grains, Oilseeds & Pulses), Formulation (Liquid, Dry), Source (Microbials, Biochemicals), Mode of Application, and Region—Forecast To 2030

The biopesticides market is projected to grow from USD 8.94 billion in 2025 to USD 17.68 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 14.6% during the forecast period. The demand for biopesticides is increasing owing to the rising popularity of organic products that have no harmful residues, the implementation of stricter rules to limit chemical pesticide residue levels, and the growing adoption of sustainable agricultural methods by farmers. Growers increasingly prefer microbial, biochemical, and botanical biopesticides for crop protection, which is conducted through integrated pest management (IPM) and precision agriculture methods. With growing awareness about the effects of synthetic chemical substances on both the environment and human health, the demand for safer, nature-based solutions has increased. The biopesticides market will witness significant growth because ongoing formulation technology improvements will create products with better field performance and make new products available for both specialty and row crops.

Biopesticides Market

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267

By type, cereals & grains segment to hold significant market share

By type, cereals and grains constitute a major segment of the biopesticides market due to their vast cultivation area and critical role in global food security. Farmers are increasingly adopting microbial, biochemical, and botanical biopesticides to manage pests, diseases, and nematodes in crops such as corn, wheat, and barley while meeting strict residue limits and regulatory requirements. This segment is supported by continuous improvements in formulation technologies, seed treatment solutions, and foliar applications that enhance product performance and reliability under diverse field conditions. Furthermore, the incorporation of biopesticides into precision agriculture systems and integrated pest management (IPM) programs enables more targeted, efficient, and sustainable crop protection strategies. The combination of large acreage under cultivation, rising demand for environmentally responsible farming practices, and sustained innovation in biological product development is driving the increased adoption of biopesticides in cereals and grains, reinforcing the segment’s strong position within the biopesticides market.

By mode of application, seed treatment segment to witness fastest growth

The seed treatment segment is expected to achieve the highest growth rate among all application methods used in the biopesticides market because farmers increasingly use microbial and biochemical products to protect seeds from pests, diseases, and nematodes. The seed-applied solutions provide specific control over pests, and they help users decrease their need for traditional chemical pesticides because the solutions work well with existing pest management methods. The development of new formulation technologies has led to improved biopesticide products that maintain their stability, adhere effectively to surfaces, and retain biological efficacy under various field trial conditions. The global biopesticides industry experiences growth through biological seed treatments, which now serve as essential elements that drive market research because of increased sustainable agriculture and precision farming practices.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267

By region, Europe to hold significant market share

Europe accounts for a substantial share of the global biopesticides market, supported by effective policy programs that encourage farmers to shift from traditional chemical pesticides to environmentally friendly crop protection methods. The combination of stricter regulations and government programs that support sustainable agriculture practices has created strong demand for biological solutions, which now benefit major agricultural sectors that include rice production and the cultivation of fruits, vegetables, and high-value crops. Manufacturers in this region have enhanced their research, production, and formulation skills, enabling them to create market-ready microbial and biochemical biopesticides at competitive prices. The market demand for agricultural products has grown because of two factors: well-established distribution networks and increased requirements for export-oriented agricultural supply chains to meet residue standards. Europe stands as a key region for the global biopesticides industry because its market consumption has grown and its industry activities have progressed.

Leading Biopesticides Companies:

The report profiles key players such as Corteva Agriscience (US), Valent BioSciences (US), BASF (Germany), Bayer CropScience (Germany), Syngenta Group (Switzerland), FMC Corporation (US), UPL (India), Marrone Bio Innovations (US), Certis Biologicals (US), Koppert Biological Systems (Netherlands), AgBiome (US), Novonesis (Denmark), Lallemand Plant Care (Canada), BioWorks Inc. (US), and Andermatt Group AG (Switzerland).

Recent Developments in the Biopesticides Industry:

  • January 2025: Syngenta Group advanced its biologicals platform with the rollout of new nature-inspired microbial and biochemical solutions supported by expanded manufacturing capacity.
  • February 2025: UPL launched Thiopron, a sulfur-based biofungicide aimed at sustainable powdery mildew control in specialty crops
  • January 2025: Valent BioSciences entered into a strategic partnership to commercialize Sweetsei and other Seipasa biostimulants in the US market.

 

Related Reports:

 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biopesticides-267.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biopesticides Market Size, Share, Latest Trends, Growth Drivers, Opportunities, Leading Key Players, and Future Outlook (2025-2030)

Thin-Film Electrode Market Outlook 2026-2030: Emerging Trends, Segment Analysis and Investment Scope

The Thin-Film Electrode market is gaining momentum driven by rising demand for compact, high-performance energy storage and flexible electronics. Growth in wearable devices, medical sensors, and next-gen batteries is accelerating innovation. As industries prioritize miniaturization and efficiency, thin-film electrode technologies are set to play a pivotal role in future electronic and energy solutions.

The thin-film electrode market is projected to grow from USD 0.57 billion in 2025 to USD 0.97 billion in 2030, at a CAGR of 11.3%. The report provides key insights into current thin-film electrode market trends, growth drivers, challenges, and opportunities shaping the market landscape. The growth of the thin-film electrode market is being fueled by the expanding role of advanced materials in biotechnology, renewable energy, and smart electronics, coupled with rising opportunities from emerging applications in flexible and wearable devices. Industries are increasingly turning to thin-film electrodes because they offer superior sensitivity, stability, and miniaturization, enabling precise electrical and electrochemical performance in compact systems. In healthcare, their integration into implantable and wearable biosensors is revolutionizing diagnostics and continuous health monitoring, while in energy applications, they enhance the efficiency and lifespan of batteries, fuel cells, and electrochemical reactors. Simultaneously, advancements in nanostructured coatings, boron-doped diamond films, and hybrid material systems are opening new possibilities for higher conductivity and corrosion resistance.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158873260

The metal-based segment is anticipated to be the largest segment in the thin-film electrode market, by material, during the forecast period (20252030).

Metal-based materials hold the largest share of the thin-film electrode market, primarily due to their excellent electrical conductivity, stability, and compatibility across a wide range of applications. Metals such as gold, platinum, silver, and titanium are widely used to form thin-film electrodes due to their superior electron transfer efficiency, corrosion resistance, and ease of fabrication through deposition techniques, such as sputtering or evaporation. These properties make them ideal for high-performance electrochemical systems, including biosensors, medical diagnostics, microelectronics, and energy storage devices. Moreover, metal-based thin-film electrodes provide consistent signal quality and low impedance, which are crucial for sensitive measurements in healthcare and environmental monitoring. Their ability to be deposited on various substrates, such as glass, silicon, or flexible polymers, also supports their integration into miniaturized and wearable electronic devices.

The physical vapor deposition segment is anticipated to be the largest segment in the thin-film electrode market, by manufacturing facility, during the forecast period (20252030).

Physical vapor deposition (PVD) dominates the manufacturing technology segment of the thin-film electrode market due to its superior control, precision, and film quality compared to other deposition techniques. PVD enables the formation of uniform, dense, and highly adherent coatings of metals, carbon, or boron-doped diamond onto a wide range of substrates, including glass, silicon, and flexible polymers. This level of precision is critical for producing thin-film electrodes used in applications such as biosensors, microelectronics, and electrochemical devices, where consistent film thickness and purity directly impact performance and reliability. Moreover, PVD processes such as sputtering and evaporation operate under controlled vacuum conditions, minimizing contamination and ensuring films with excellent electrical conductivity and surface smoothness. These characteristics enhance electrode sensitivity and signal stability, which are essential for high-end analytical and sensing applications.

The electronics & semiconductor segment is anticipated to be the largest segment in the thin-film electrode market by end-use industry during the forecast period (20252030).

The electronics & semiconductor industry dominates the end-use segment of the thin-film electrode market because of its extensive use of precision electrodes in microelectronic devices, sensors, and advanced circuit systems. Thin-film electrodes play a crucial role in enabling the development of miniaturized, high-performance, and energy-efficient electronic components, such as transistors, integrated circuits, and microelectromechanical systems (MEMS). These electrodes provide the essential electrical pathways required for signal transmission and charge transfer within semiconductor devices, where uniformity, stability, and conductivity are critical. The growing demand for compact and flexible electronic devices, including smartphones, wearables, and IoT sensors, has further boosted the adoption of thin-film electrode technology in this sector. Thin-film electrodes are integral to semiconductor fabrication and testing, especially in wafer-level processing, photolithography, and surface modification. The increasing investment in next-generation technologies, such as AI chips, 5G infrastructure, and advanced sensors, has also expanded their application scope in both front-end and back-end semiconductor manufacturing.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158873260

Asia Pacific is expected to be the largest region in the global thin-film electrode market, by region, during the forecast period (20252030).

Asia Pacific is expected to emerge as the largest region in the global thin-film electrode market during the forecast period, driven by its strong manufacturing ecosystem, rapid industrialization, and expanding electronics and healthcare sectors. The region is home to some of the world’s leading producers of semiconductors, sensors, and electronic materials, particularly in countries such as China, Japan, South Korea, and Taiwan, which are major hubs for thin-film deposition and microfabrication technologies. The increasing investment in advanced material research, nanotechnology, and precision manufacturing has also strengthened the region’s capability to produce high-quality thin-film electrodes for a wide range of applications. In addition, Asia Pacific’s growing focus on healthcare innovation and renewable energy systems is creating new opportunities for thin-film electrode integration in biosensors, energy storage devices, and electrochemical treatment systems.

Thin-Film Electrode Companies

To enable an in-depth understanding of the competitive landscape, the report profiles some top players in the thin-film electrode market: BASi Research Products, Inc. (US), MicruX Technologies (Spain), Merck KGaA (Germany), Flex Medical Solutions Ltd (Scotland), PalmSens (Netherlands), MSE Supplies LLC (US), and Metrohm DropSens (Spain).

BASi Research Products, Inc. (US)

Founded in 1974, BASi Research Products, Inc. has established itself as a trusted global supplier of precision instrumentation for the life sciences and electrochemistry markets. The company became part of Inotiv, Inc., a publicly traded research services organization headquartered in Indianapolis, Indiana, following its merger in 2020. BASi’s instruments and consumables are manufactured in West Lafayette, Indiana, where the company’s engineering and production teams emphasize innovation, reproducibility, and scientific precision. The firm’s product range spans electrochemical analyzers, electrodes, and accessories, catering to applications in drug discovery, contaminant detection, material characterization, and point-of-care diagnostics. One of its notable offerings includes thin-film electrodes. While BASi’s core operations are US-based, it benefits from being a part of Inotiv, Inc., a publicly traded global research organization. Inotiv operates with a workforce of over 2,000 employees across 20+ international facilities, providing contract research services, animal models, and specialized scientific products worldwide. Through this parent company’s extensive network, BASi gains access to a global research ecosystem and collaborative opportunities while retaining its specialized focus on electrochemistry and analytical instrumentation.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=158873260

MicruX Technologies (Spain)

MicruX Technologies, founded in 2008 as a spin-off from the University of Oviedo, Spain, emerged from the collaboration of two leading research groups: the Immunoelectroanalysis Group, led by Professor Agustin Costa-García, and the Optoelectronics Group, led by Professor Jose Rodríguez-García. The company focuses on developing and manufacturing innovative solutions in microfluidic devices, electrochemical transducers, and miniaturized analytical instrumentation, leveraging advanced Lab-on-a-Chip technologies. MicruX offers a comprehensive portfolio of electrodes based on thin-film and screen-printing technologies, alongside portable platforms and instruments for electrochemical analysis. The company excels in custom electrode development, providing end-to-end solutions from design and prototyping to large-scale production, ensuring tailored solutions that meet specific client requirements.

Headquartered in Spain, MicruX maintains a strong presence across the European Union while extending its reach globally through distributors in regions including Asia Pacific, North America, the UK, and the Middle East & Africa.

Merck KGaA (Germany)

Merck KGaA, a German science and technology company, is the world’s oldest operating chemical and pharmaceutical company. It specializes in the development and manufacturing of chemical and pharmaceutical products, offering one of the most comprehensive portfolios in the industry for scientists, pharmaceutical development, and manufacturing. In the US and Canada, its Life Science division operates under the MilliporeSigma brand. Globally, Merck KGaA has a presence in 66 countries, employing over 60,000 people. The company is structured into three business sectors. The Life Science division supplies tools, chemicals, and equipment for academic research labs, biotech, pharmaceutical manufacturing, and industrial applications. The Healthcare sector focuses on the discovery, development, manufacturing, and marketing of prescription drugs and biopharmaceuticals. Meanwhile, the Electronics division provides essential materials for the semiconductor, display, and surface design industries. Each sector has its own unique products, services, customer base, sales structure, and regulatory framework, collectively strengthening Merck KGaA’s extensive global presence across all continents.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/thin-film-electrode-market-158873260.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Thin-Film Electrode Market Outlook 2026-2030: Emerging Trends, Segment Analysis and Investment Scope

Dietary Supplements Market Size, Share, Leading Companies, Emerging Trends, Growth Drivers, and Future Outlook (2025-2030)

“MarketsandMarkets™”
Dietary Supplements Market by Type (Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics), Mode of Application (Tablets, Capsules, Liquid, Powder, Gummies/Chewables), Target Consumer, Function, Region – Global Forecast to 2030

The global dietary supplements market is projected to grow from USD 192.60 billion in 2025 to USD 278.41 billion by 2030, registering a robust CAGR of 7.6% during the forecast period, according to the latest market analysis. The market’s growth is being fueled by increasing consumer preference for health supplement products, rising preventive healthcare adoption, the growing burden of chronic ailments, and heightened awareness of micronutrient deficiencies.

Dietary Supplements Market

The rapid expansion of the dietary supplements market is attributed to growing nutrition awareness, the adoption of healthy lifestyles, and the rise of e-commerce and online retail platforms, which have significantly improved consumer access to dietary supplements.

Key Takeaways:

  • North America is estimated to account for a 33.3% share of the market in 2025.
  • By type, the botanical segment is expected to register a significant CAGR of 8.1%.
  • By target consumer, the adult segment is projected to dominate the market during the forecasted period.
  • By function, the sports nutrition segment is projected to grow at the highest CAGR during the forecasted period
  • By mode of application, the capsules segment is estimated to hold a significant market share.
  • Nestlé, Abbott, and Haleon Group of Companies were among the companies identified as star players in the global dietary supplements market, given their strong market share and product footprint.
  • Amway Corp., American Health, and others have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=973

Market Insights by Type

Among supplement types, vitamins are expected to hold the largest share in 2024. Increasing consumer recognition of the role vitamins play in overall health and wellness has driven demand for vitamin-based dietary supplements.

Market Insights by Target Consumer

The adult segment is projected to dominate the dietary supplements market in 2024. This trend reflects growing health consciousness, the desire to manage specific health conditions or deficiencies, and the rising aging population seeking preventive healthcare solutions.

Market Insights by Mode of Application

Capsules account for the largest market share, as consumers perceive them to offer better nutrient absorption compared to tablets. Capsules also provide a convenient and user-friendly form, contributing to their popularity.

Regional Market Outlook

North America is anticipated to hold the largest share of the global dietary supplements market in 2024. The region’s dominance is supported by the high prevalence of chronic diseases and strong consumer awareness of the health benefits associated with dietary supplements.

Leading Dietary Supplements Companies:

The global dietary supplements market features several leading companies, including Nestlé (Switzerland), Abbott (US), Amway Corp (US), Otsuka Holdings Co., Ltd (Japan), Glanbia PLC (Ireland), Bayer AG (Germany), Haleon Group of Companies (UK), Herbalife International of America, Inc. (US), Nature’s Sunshine Products, Inc (US), Bionova (India), Arkopharma (France), American Health (US), H&H Group (Hong Kong), Nu Skin (US), and Vitaco (New Zealand).

Recent Developments in the Dietary Supplements Industry:

  • August 2025: Vitanergy Health US Inc. launched three new products: D3 multivitamin gummies, B-Complex gummies with folate, and a “Rejuvenate & Glow” 4-in-1 capsule, targeting women’s daily nutritional needs with the inclusion of clean-label and vegan-friendly formulations.
  • June 2025: Nature’s Bounty launched products that addressed women’s wellness, healthy longevity, and digestive health. The product included supplements such as Advanced Menopause Relief, Ultra Collagen Booster Capsules, Advanced Vital Heart, Superfoods Plus Energy, and Prebiotic + Postbiotic + Probiotic Gummies.
  • November 2024: Nestlé expanded its Materna brand portfolio with the launch of two new products, Materna Pre and Materna Nausea. These products are designed to address critical needs in women’s fertility and pregnancy. This innovation reflects the company’s strategic focus on maternal health.

 

Related Reports:

North America Dietary Supplements Market

Asia Pacific Dietary Supplements Market

Europe Dietary Supplements Market

 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/dietary-supplements-market-973.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dietary Supplements Market Size, Share, Leading Companies, Emerging Trends, Growth Drivers, and Future Outlook (2025-2030)

Photovoltaic Films Market Set for Rapid Growth Analysis: Trends, Demand, Size, and Key Player Forecast 2030

The Photovoltaic Films market is gaining momentum as demand rises for lightweight, flexible, and cost-efficient solar solutions across buildings, vehicles, and portable electronics. Advancements in thin-film technologies, supportive renewable policies, and growing focus on energy-efficient infrastructure are expected to drive steady adoption, positioning photovoltaic films as a key enabler of next-generation solar energy systems.

The photovoltaic films market size is projected to grow from USD 14.05 billion in 2025 to USD 29.01 billion by 2030, registering a CAGR of 15.6% during the forecast period. The report provides key insights into current photovoltaics films market trends, growth drivers, challenges, and opportunities shaping the market landscape. The market for photovoltaic films is expanding, driven primarily by emerging technologies, such as Tunnel Oxide Passivated Contact (TOPCon) and Heterojunction Technology (HJT), that need encapsulation designed specifically for them to be successful. TOPCon and HJT cells have steadily improving efficiencies and energy conversion rates over existing silicon-based cells, making them the most widely implemented technologies in the solar industry. They are, however, more susceptible to environmental conditions that require advanced encapsulation films with improved UV protection, thermal stability, and electrical insulation. HJT cells, which have crystalline silicon combined with hybrid amorphous silicon layers, are an example of the necessity of films to mitigate potential-induced degradation (PID).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=147989535

PVB films based is anticipated to be the largest segment in photovoltaics films market, by raw material, in terms of value, during the forecast period

PVB films account for the largest share of the photovoltaic films market. The preferred choice for encapsulation films is likely a result of its excellent physical and chemical properties, and compatibility with new PV (photovoltaic) technology. PVB was first developed for laminated safety glass use in the automotive and construction industries. The films have some prized benefits, such as superior adhesion to glass, high optical clarity, and stronger protection from UV and moisture from extreme environmental conditions in regions, such as the Middle East & Africa, with high heat, sand, and UV exposure. Furthermore, PVB provides structural support by enhancing the mechanical strength and impact resistance of the panel assembly, helping protect it from damage during transportation, installation, or exposure to adverse weather conditions. Much of the damage can lead to loss of efficiency and even shorten the product life of the solar panel. However, with new advances in bifacial and building integrated photovoltaics (BIPV) that use glass-glass module combinations, demand is expected to grow for encapsulation materials like PVB.

Ground is projected to be the largest segment in the photovoltaics films market, by application, during the forecast period

Ground solar applications constitute the largest share in the application segment of the global market for photovoltaic films because the geography, infrastructure, and economy in many regions support the deployment of large-scale solar energy. Globally, semi-arid and arid land areas with low vegetation cover and minimal land-use conflicts make them suitable for utility-scale solar installations. Ground-mounted photovoltaic (PV) systems and installations, particularly utility-scale solar farms, are heavily reliant on films since large quantities of encapsulation films are necessary to protect solar panels and enhance the durability and service life of solar panels that are subjected to harsh climate, energy, extreme UV radiation exposures, high temperatures, sand storms and high humidity conditions in coastal zones. Ground systems also provide optimal utilization of PV to achieve maximum energy yield with maximum power point tracking, coupled with ideal orientation/solar tracking, which is increasingly significant in areas experiencing rapid urbanization and industrialization.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147989535

Asia Pacific is expected to be the largest region in the photovoltaics films market, during the forecast period

Asia Pacific accounts for the largest share of the photovoltaic films market, owing to its strong manufacturing industries and rapidly developed solar energy sector. China, India, Japan, and South Korea continue to be leaders in deploying solar energy, with an active push to promote the use of renewable energy by the government. China is home to many of the global leaders in solar panel manufacturing, which creates great demand for encapsulation films that enclose and protect the solar cells and meet module efficiencies. Asia Pacific has local producers of encapsulation materials and a geographically well-established supply chain that enables producers to get high-quality, inexpensive substrate material. Thus, the region has heavily invested in energy security and promotes energy sustainability, which has led to considerable utility-scale solar development and rooftop installations. Encouraging policies like subsidies and long-term solar install targets also spur momentum. Moreover, skilled labor and access to raw materials provide a competitive advantage in the supply of photovoltaic films.

Photovoltaics Films Companies

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the photovoltaics films market such as H.B. Fuller Company (US), 3M (US), Kuraray Co., Ltd (Japan), JA SOLAR Technology Co., Ltd. (China), Borealis AG (Austria)., Jiangsu Sveck Photovoltaic New Material Co., Ltd (China), HANGZHOU FIRST APPLIED MATERIAL CO.,LTD. (China), Shanghai HIUV New Materials Co.,Ltd. (China), Guangzhou Lushan New Materials Co., Ltd. (China), Betterial (China), Mitsui Chemicals, Inc. (Japan), Hanwha Group (South Korea), Zhejiang Sinopont Technology Co.,Ltd. (China), and Cybrid Technologies Inc. (China).

Hanwha Group, founded in 1952, is a diversified conglomerate and the seventh-largest business enterprise in South Korea. The Group operates through a balanced portfolio that includes various sectors: Aerospace & Mechatronics, Clean Energy & Ocean Solutions, Finance, and Retail & Services. The Clean Energy & Ocean Solutions segment encompasses various subsidiaries such as Hanwha Solutions, Hanwha Ocean, Hanwha Energy, Hanwha Impact, Hanwha Power Systems, Hanwha TotalEnergies Petrochemical, Hanwha Engine, and Hanwha Advanced Materials. The Group manufactures PV encapsulant EVA sheets through Hanwha Advanced Materials.

3M, established in 1902, is a diversified technology and manufacturing company headquartered in Minnesota, US. 3M’s business portfolio comprises three distinct segments: Safety and Industrial, Transportation and Electronics, and Consumer. The company manufactures PV films under its Safety and Industrial division. 3M’s Safety and Industrial division encompasses a wide range of products designed to enhance safety and efficiency across various industrial applications. This division includes offerings such as industrial abrasives and finishing solutions for metalworking, electrical products and materials for construction and maintenance, power distribution and electrical original equipment, structural adhesives and tapes, as well as natural and color-coated mineral granules used in roofing shingles.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=147989535

HANGZHOU FIRST APPLIED MATERIAL CO., LTD. is a leading Chinese company founded in 2003, specializing in the research, development, production, and distribution of photovoltaic packaging materials. The company offers a broad product portfolio that includes PV materials, PCB/FPC, electronic components, and hot-melt web. In the PV materials segment, it produces ethylene/vinyl acetate (EVA) films, polyolefin (PO) films, and backsheets specifically designed for photovoltaic modules. Notably, its Solar EVA Film holds over 50% of the global market share, forming strong partnerships with many well-known PV companies and greatly impacting the PV films market.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/photovoltaics-pv-films-market-147989535.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Photovoltaic Films Market Set for Rapid Growth Analysis: Trends, Demand, Size, and Key Player Forecast 2030

Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL-Supported Clinical Evaluation – More Stocks Inside

Rapid Dose Therapeutics (CSE: DOSE; OTCQB: RDTCF), a biotechnology and drug delivery innovation company, is accelerating clinical validation of its proprietary QuickStrip™ oral thin film delivery system through expanded cannabinoid research and a high-profile study supported by the National Football League (NFL).

Independent research led by university investigators is examining the role of naturally produced cannabinoids in pain management, concussion recovery, and neuroprotection in contact sports, highlighting growing institutional interest in cannabinoid therapeutics and sports medicine innovation.

Stocks to Watch Under $1: Ensysce Biosciences (NASDAQ: ENSC), OneMedNet Inc (NASDAQ: ONMD), Veea Inc (NASDAQ: VEEA), TMD Energy Ltd (NYSE: TMDE) and Kartoon Studios (NYSE: TOON) trading actively in early trading now!

In parallel, a clinical study is evaluating the bioavailability of CBD delivered via QuickStrip™ compared to traditional oral formats. The research measures pharmacokinetic data, including CBD plasma concentration and absorption efficiency, to determine whether oral thin film delivery enhances systemic uptake. More than 60% of participant data has been extracted, with enrollment continuing through Q2 2026, alongside real-time and accelerated stability testing.

If clinical data confirm improved absorption and rapid onset, QuickStrip™ could significantly strengthen its positioning within the oral thin film drug delivery market, the CBD clinical research sector, and the broader pharmaceutical and nutraceutical industries. Watch QuickStrip™ Drug Delivery System Video Now!

Management believes QuickStrip™ represents a next-generation patient delivery system designed to disrupt traditional capsules, oils, and tablets by offering rapid, discreet, and controlled dosing. With applications spanning pharmaceutical drug delivery, wellness products, nicotine alternatives, and cannabinoid therapeutics, the platform is being positioned as a scalable solution capable of reshaping how active ingredients are administered in both medical and consumer markets.

For investors searching “CSE biotech stocks,” “OTCQB life sciences companies,” “oral thin film delivery technology,” and “CBD clinical trial stocks,” Rapid Dose Therapeutics continues to build a data-driven case for platform validation and long-term growth.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL-Supported Clinical Evaluation – More Stocks Inside

Paramount (NASDAQ: PSKY) Wins Warner Bros. (NASDAQ: WBD) – What It Means for NFLX, TOON, AMC and AMCX

Paramount (NASDAQ: PSKY) has reshaped the media landscape after winning its bidding war for Warner Bros. Discovery (NASDAQ: WBD) in a deal valuing the combined assets at approximately $111 billion. The acquisition consolidates Warner’s studios, streaming platforms, and television networks under Paramount’s expanding media umbrella.

At the same time, Netflix (NASDAQ: NFLX) moved higher after deciding not to raise its $83 billion bid, emphasizing financial discipline. Investors welcomed the move, reinforcing a broader shift in the streaming sector toward profitability, free cash flow, and disciplined capital allocation.

A Maturing Streaming Market

For investors tracking “streaming industry consolidation,” “media stocks 2026,” and “Netflix stock outlook,” the message is clear: growth-at-any-cost is giving way to strategic integration and return on investment. Fewer mega-platforms may now control larger content ecosystems.

Opportunity for Smaller Content Players

In this environment, independent studios like Kartoon Studios (NYSE American: TOON) could benefit. As major conglomerates streamline operations, demand may increase for cost-efficient licensed programming, children’s content, and franchise-ready intellectual property. Smaller IP-driven companies may gain leverage through partnerships and distribution agreements.

The Theatrical Angle: AMC

Studio consolidation also impacts theatrical exhibition. AMC Entertainment (NYSE: AMC) remains closely tied to blockbuster release strategies. A more concentrated studio landscape may prioritize tentpole franchises and premium global rollouts, which historically support box office performance and premium cinema formats.

AMC Networks (NASDAQ: AMCX): A Hybrid Player

AMC Networks (NASDAQ: AMCX) occupies a strategic middle ground with its portfolio of targeted streaming services including AMC+, Acorn TV, Shudder, Sundance Now, ALLBLK and HIDIVE, alongside cable brands such as AMC and BBC AMERICA. Its vertically integrated model — spanning streaming, cable, film distribution, and AMC Studios — positions it uniquely as media consolidation accelerates.

Investor Takeaway

The Paramount–Warner deal signals a structural shift in the entertainment industry. Netflix’s disciplined exit underscores investor demand for capital efficiency. Meanwhile, companies across the spectrum — from mega-cap consolidators (PSKY, WBD) to streamers (NFLX), niche content creators (TOON), theatrical exhibitors (AMC), and hybrid media operators (AMCX) — may all be impacted as the streaming wars evolve into a profitability-driven era.

As media consolidation deepens, intellectual property strength, operational discipline, and targeted audience engagement may define the next generation of media winners.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Paramount (NASDAQ: PSKY) Wins Warner Bros. (NASDAQ: WBD) – What It Means for NFLX, TOON, AMC and AMCX

Las Vegas Artificial Grass Expands Services to Meet Growing Demand for Water-Saving Outdoor Solutions Across the Valley

“Every week we speak with homeowners who are done fighting the desert to keep natural grass alive. Between the water bills, the maintenance, and the brown patches every summer, artificial grass isn’t just a lifestyle upgrade in Las Vegas it’s the practical choice.” – Spokesperson, Las Vegas Artificial Grass”
Las Vegas Artificial Grass, a locally owned synthetic turf and outdoor design company based in Las Vegas, NV, announces expanded residential and commercial installation services across the Las Vegas valley as Southern Nevada homeowners and businesses increasingly seek water-efficient alternatives to natural grass amid tightening SNWA conservation mandates.

LAS VEGAS, NV – February 27, 2026 – Las Vegas Artificial Grass, headquartered at 3080 S Durango Dr Suite 102, Las Vegas, NV 89117, today announced the expansion of its residential and commercial outdoor installation services across the greater Las Vegas valley. The announcement comes amid a significant increase in homeowner and business inquiries driven by tightening Southern Nevada Water Authority conservation requirements and rising water utility costs throughout the region.

The company now offers a comprehensive range of outdoor design and installation services including professional artificial grass installation for front yards, backyards, and side yards; pet-friendly turf engineered for households with dogs; custom backyard putting greens; paver installation for patios, driveways, and pool surrounds; hardscape installation including retaining walls, steps, and raised planters; desert plant installation; irrigation systems; outdoor kitchens; outdoor lighting; and patio covers and pergolas.

Addressing a Growing Water Conservation Challenge

The Las Vegas valley receives an average of just four inches of rainfall annually, making it one of the driest metropolitan areas in the United States. According to the Southern Nevada Water Authority, a standard residential natural grass lawn consumes approximately 50 to 70 gallons of water per square foot each year. For a typical Las Vegas residential lawn, this represents tens of thousands of gallons of water annually — a significant and growing expense as SNWA tiered rate structures penalize high water consumption.

Las Vegas Artificial Grass eliminates lawn irrigation almost entirely, offering homeowners and businesses a permanent solution that reduces water consumption, eliminates ongoing lawn maintenance costs, and delivers a consistently green, professional appearance year-round regardless of heat, drought, or foot traffic.

The SNWA currently offers rebates to residential and commercial property owners who remove qualifying natural grass and replace it with water-efficient alternatives. Las Vegas Artificial Grass assists clients through the full rebate documentation process, providing square footage certification, pre-installation photography, and product specifications required by the SNWA to support rebate applications.

Serving Homeowners and Businesses Across the Valley

Las Vegas Artificial Grass serves clients throughout Las Vegas, Henderson, North Las Vegas, Summerlin, Green Valley, Anthem, Boulder City, and surrounding communities. The company works with HOA communities across the valley’s major master-planned neighborhoods and is familiar with the appearance standards and approval processes of Henderson’s Green Valley, Anthem, Inspirada, and Summerlin communities.

Homeowners and businesses interested in learning more or scheduling a free on-site consultation can visit the company’s website at https://lasvegasartificialgrass.org or find the business on Google Maps at https://maps.app.goo.gl/ypLP1Sfx5Tv7fbWR7

Commercial clients include office buildings, retail properties, hotels, apartment complexes, HOA common areas, schools, and sports facilities. The company’s commercial installation division uses heavy-duty turf products rated for high-traffic use with manufacturer warranties of up to 15 years, and assists commercial clients through SNWA rebate applications for qualifying large-area natural grass removal projects.

Professional Installation Standards

Las Vegas Artificial Grass emphasizes base preparation and drainage engineering as the foundation of every installation. All pet turf projects include antimicrobial infill as standard. The company provides free on-site consultations throughout the valley, typically within 48 hours of contact, and delivers fixed-price quotes with no hidden fees before any work begins.

Free consultations can be scheduled by calling 702-757-4433, emailing lvarigrass@gmail.com, or visiting https://lasvegasartificialgrass.org

About Las Vegas Artificial Grass

Las Vegas Artificial Grass is a locally owned and operated outdoor design and installation company serving the greater Las Vegas valley. The company installs artificial turf, pavers, hardscape, desert plants, irrigation systems, outdoor kitchens, lighting, and patio covers for residential and commercial clients throughout Las Vegas, Henderson, Summerlin, North Las Vegas, Green Valley, Anthem, and Boulder City.

Media Contact: Las Vegas Artificial Grass 3080 S Durango Dr, Suite 102 Las Vegas, NV 89117 Phone: 702-757-4433 Email: lvarigrass@gmail.com Website: https://lasvegasartificialgrass.org Google Business Profile: https://maps.app.goo.gl/ypLP1Sfx5Tv7fbWR7

Media Contact
Company Name: Las Vegas Artificial Grass
Email: Send Email
Phone: (702) 757-4433
Address:3080 S Durango Dr Suite 102
City: Las Vegas
State: Nevada
Country: United States
Website: https://lasvegasartificialgrass.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Las Vegas Artificial Grass Expands Services to Meet Growing Demand for Water-Saving Outdoor Solutions Across the Valley

Wegic AI Reflects Growing Demand for Conversational AI Website Builders

“A workspace featuring a laptop and desktop computer, illustrating tools like Wegic AI used for website development and digital creation.”
Wegic AI offers conversational AI website building tools for startups, businesses and creators. The promo code SAVE2026 provides 10% off sitewide throughout 2026 when used at wegic.ai.

The Wegic AI promo code SAVE2026 provides 10% savings sitewide throughout 2026 when applied at wegic.ai. Users searching for a Wegic AI discount code can use SAVE2026 at checkout on eligible plans.

As AI-powered website builders continue expanding across the digital tools market, Wegic AI has emerged as a conversational AI platform designed to simplify website creation. Entrepreneurs, startups, agencies and creators exploring AI-driven site development frequently search for a Wegic AI promo code before subscribing.

Currently, the promo code SAVE2026 provides 10% off sitewide through 2026 when used at wegic.ai.

Conversational AI Website Creation

Wegic AI positions itself as a no-code website builder powered by conversational artificial intelligence. Rather than manually selecting templates and configuring layouts, users describe their business goals, services, or personal brand direction in natural language. The platform then generates structured website drafts, layout suggestions and AI-assisted content.

This approach appeals to:

  • Startup founders launching MVP landing pages

  • Creators building portfolio sites

  • Agencies testing campaign pages

  • Small businesses establishing an online presence

  • Entrepreneurs seeking rapid deployment without coding


Growing Demand for AI Website Builders

The rise of generative AI tools has accelerated adoption of automated website creation platforms. Businesses increasingly prioritize:

  • AI-generated content assistance

  • Automated page structuring

  • Responsive design optimization

  • Streamlined publishing workflows

Wegic AI operates within this expanding category, offering an AI-first workflow intended to reduce time-to-launch.

Individuals researching the platform often search for terms such as:

  • Wegic AI promo code

  • Wegic AI discount code

  • Wegic AI coupon

  • Wegic AI pricing

  • Wegic AI review

For those evaluating pricing options, the code SAVE2026 remains active for 10% savings sitewide when applied directly via wegic.ai.

Evaluating Features and Suitability

As with any AI software platform, prospective users may consider:

  • Ease of onboarding

  • Customization flexibility

  • Hosting and deployment capabilities

  • Ongoing subscription structure

  • AI content editing controls

Complete feature information and current plan details are available at wegic.ai.

Availability of Promotional Savings

Readers comparing AI website builder platforms and searching specifically for a Wegic AI promo code can use SAVE2026 to receive 10% off sitewide throughout 2026, subject to eligibility at checkout on the official website.

This article is provided for informational purposes and references third-party AI software tools within the website builder sector.

Media Contact
Company Name: Trivas
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: wegic.ai

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Wegic AI Reflects Growing Demand for Conversational AI Website Builders